Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[No title available]
[No authors listed] [No authors listed] PMID: 36161820
External Validation of the 2003 Leibovich Prognostic Score in Patients Randomly Assigned to SORCE, an International Phase III Trial of Adjuvant Sorafenib in Renal Cell Cancer.
Oza B, Eisen T, Frangou E, Stewart GD, Bex A, Ritchie AWS, Kaplan R, Smith B, Davis ID, Stockler MR, Albiges L, Escudier B, Larkin J, Joniau S, Hancock B, Hermann GG, Bellmunt J, Parmar MKB, Royston P, Meade A. Oza B, et al. Among authors: royston p. J Clin Oncol. 2022 Jun 1;40(16):1772-1782. doi: 10.1200/JCO.21.01090. Epub 2022 Feb 25. J Clin Oncol. 2022. PMID: 35213214 Free PMC article. Clinical Trial.
A combined test for a generalized treatment effect in clinical trials with a time-to-event outcome.
Royston P. Royston P. Stata J. 2017 Apr;17(2):405-421. Stata J. 2017. PMID: 29445320 Free PMC article.
Nonproportional hazards are seen increasingly in trials and are recognized as a potential threat to the power of the log-rank test. To address the issue, Royston and Parmar (2016, BMC Medical Research Methodology 16: 16) devised a new "combined test" of the global null hyp …
Nonproportional hazards are seen increasingly in trials and are recognized as a potential threat to the power of the log-rank test. To addre …
Combined test versus logrank/Cox test in 50 randomised trials.
Royston P, Choodari-Oskooei B, Parmar MKB, Rogers JK. Royston P, et al. Trials. 2019 Mar 18;20(1):172. doi: 10.1186/s13063-019-3251-5. Trials. 2019. PMID: 30885277 Free PMC article.
We compared the results from the logrank/Cox test with those from the combined test recently proposed by Royston and Parmar. RESULTS: The PH assumption was checked and reported only in 28% of the studies. ...The degree of non-PH and the dominance of the p value for …
We compared the results from the logrank/Cox test with those from the combined test recently proposed by Royston and Parmar. RESULTS: …
Re: Spline-based accelerated failure time model.
Clements M, Christoffersen B, Royston P, Crowther M. Clements M, et al. Among authors: royston p. Stat Med. 2022 Mar 30;41(7):1314-1315. doi: 10.1002/sim.8964. Stat Med. 2022. PMID: 35266574 No abstract available.
185 results